UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "AdministrableProductDefinition",
"id" : "LidokainAgu-20mgml-InjSol-SE-AJ-APD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition LidokainAgu-20mgml-InjSol-SE-AJ-APD</b></p><a name=\"LidokainAgu-20mgml-InjSol-SE-AJ-APD\"> </a><a name=\"hcLidokainAgu-20mgml-InjSol-SE-AJ-APD\"> </a><a name=\"hcLidokainAgu-20mgml-InjSol-SE-AJ-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-LidokainAgu-20mgml-InjSol-SE-AJ-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000357-00056123,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection in pre-filled syringe; indication = Lidokain Aguettant är avsett för infiltrationsanestesi och perifer nervblockad. Lidokain Aguettant 10 mg/ml är avsett för vuxna och barn över 2 år. Lidokain Aguettant 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073863}\">Solution for injection</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-LidokainAgu-20mgml-InjSol-SE-AJ-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection; unitOfPresentation = Syringe</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073595}\">Intradermal use</span></p></blockquote><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073633}\">Subcutaneous use</span></p></blockquote><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000075554}\">Submucosal use</span></p></blockquote></div>"
},
"status" : "active",
"formOf" : [
{
🔗 "reference" : "MedicinalProductDefinition/LidokainAgu-20mgml-InjSol-SE-AJ-MPD"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073863",
"display" : "Solution for injection"
}
]
},
"producedFrom" : [
{
🔗 "reference" : "ManufacturedItemDefinition/LidokainAgu-20mgml-InjSol-SE-AJ-MID"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073595",
"display" : "Intradermal use"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073633",
"display" : "Subcutaneous use"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000075554",
"display" : "Submucosal use"
}
]
}
}
]
}